US FDA Targets Expanding Conduit For Supplement GMP Compliance Information

Gathering GMP information can be as problematic for agency as keeping tabs on all supplements available to US consumers. “Just to be clear, FDA believes we have a data gap in understanding the extent of the dietary supplements in the marketplace,” says ODSP Director Cara Welch.

• Source: Shutterstock

Filling holes in data about the US dietary supplement industry and gaining more knowledge about what’s available requires more information for the Food and Drug Administration about manufacturing facilities as well products in the marketplace.

Gathering information on manufacturers can be as problematic for the agency’s Office of Dietary Supplement Programs, however, as keeping tabs...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation